Alternative Medicine and Alzheimer Disease
- 1 September 2008
- journal article
- review article
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 14 (5), 299-306
- https://doi.org/10.1097/nrl.0b013e318172cf4d
Abstract
Background: Complimentary and alternative medicine has an extensive worldwide history and is commonly used by older patients. A number of different alternative medicines are used by patients having Alzheimer disease. It is both desirable and expected for clinicians to be acquainted with these medications. Review Summary: This paper discusses the available clinical trial evidence regarding 8 agents commonly used by people having Alzheimer disease. We provide an overview of the history and basic scientific evidence available for each agent, followed by a critical analysis of the evidence available from clinical trials, including the number of participants, trial duration, and specific outcomes evaluated. Conclusion: Although many of these compounds have been associated with interesting basic science, none has shown clear clinical benefit to date. Data available for some, such as Ginkgo biloba, curcumin, and huperzine A, suggest that further evaluation is warranted. Familiarity with this literature will allow clinicians to provide meaningful recommendations to patients who wish to use these agents.Keywords
This publication has 69 references indexed in Scilit:
- Protection by EGb 761 against β-amyloid-induced neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formationFree Radical Biology & Medicine, 2006
- The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementiaContemporary Clinical Trials, 2006
- Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitineEuropean Journal Of Cancer, 2005
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal ModelsAnnals of the New York Academy of Sciences, 2004
- The Lowdown on Ginkgo BilobaScientific American, 2003
- Vinpocetine for cognitive impairment and dementiaCochrane Database of Systematic Reviews, 2003
- The Clinical Safety of High-Dose Piracetam - Its Use in the Treatment of Acute StrokePharmacopsychiatry, 1999
- Acetyl-L-Carnitine in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1995
- Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administrationNeurobiology of Aging, 1987